Amster Labs IPO IPO

SME[.] – [.]

Open

[.]

Allotment

—

Listing

[.]

Issue Size

53,08,800 shares (agg. up to ₹[.] Cr)

Listing Date

[.]

✦ AI Insight

Restated Financials (₹ Cr.)

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	110.63	75.38	69.05
Total Income	35.50	105.29	96.97
Profit After Tax	5.80	2.43	1.23
NET Worth	16.55	11.78	9.44
Reserves and Surplus	9.12	8.36	6.03
Total Borrowing	39.99	28.88	24.89
Amount in ₹ Crore

Company	Issue Type	Issue Size	Issue Price	PE Ratio	Listing Day Close	Listing Gain/Loss %	LTP
Bio Medica Laboratories Ltd.	SME	₹52.43 Cr	₹139	13.03	₹115.80	-16.69%	₹158.00
Goldline Pharmaceutical Ltd.	SME	₹11.61 Cr	₹43	10.47	₹56.77	+32.02%	₹36.50
Speciality Medicines Ltd.	SME	₹29.14 Cr	₹124	9.27	₹125.90	+1.53%	₹166.00
Accretion Nutraveda Ltd.	SME	₹24.77 Cr	₹129	26.27	₹191.20	+48.22%	₹270.00
KRM Ayurveda Ltd.	SME	₹77.49 Cr	₹135	17.32	₹180.70	+33.85%	₹307.70
Curis Lifesciences Ltd.	SME	₹27.52 Cr	₹128	12.44	₹141.00	+10.16%	₹198.35
Aptus Pharma Ltd.	SME	₹13.02 Cr	₹70	11.29	₹84.84	+21.20%	₹339.90
Symbiotec Pharmalab Ltd.	Mainboard	₹1,757.00 Cr	₹988	55.44	₹1,097.70	+11.10%	₹1,133.45
Hexagon Nutrition Ltd.	Mainboard	₹138.87 Cr	₹45	22.69	₹53.19	+18.20%	₹67.99
Sai Parenteral's Ltd.	Mainboard	₹408.79 Cr	₹392	72.19	₹405.70	+3.49%	₹523.35
Corona Remedies Ltd.	Mainboard	₹655.37 Cr	₹1062	43.47	₹1,438.40	+35.44%	₹2,236.10
Rubicon Research Ltd.	Mainboard	₹1,377.50 Cr	₹485	55.75	₹628.20	+29.53%	₹1,835.40

#	Issue Objects	Est Amt (₹ Cr.)
1	Setting up of new manufacturing unit and unification of existing divisions	15.00
2	Working Capital Requirement	15.00
3	General Corporate Purposes

Updated on May 18, 2026

Amster Labs Ltd. AddressSCO 166-167, Level 1,Sector 9C, Madhya Marg,Sector 9Chandigarh, Chandigarh, 1600090172-4183370cs@amsterlabs.inVisit Website